• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中巨噬细胞功能的改变。

Altered macrophage function in chronic obstructive pulmonary disease.

机构信息

1 Department of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

Ann Am Thorac Soc. 2013 Dec;10 Suppl:S180-5. doi: 10.1513/AnnalsATS.201305-123AW.

DOI:10.1513/AnnalsATS.201305-123AW
PMID:24313770
Abstract

The observation that macrophages are increased in chronic obstructive pulmonary disease (COPD) and are associated with COPD severity has led to a large number of studies on macrophage function in COPD. These studies have provided evidence that these cells contribute to tissue injury through the release of various mediators, including proteases such as matrix metalloprotease-12. In addition, it was found that macrophages in COPD have an impaired ability to clear respiratory pathogens and apoptotic cells. Macrophage phagocytic function in COPD can be restored at least in part, as shown by in vitro studies. In a search to further understand this altered function of macrophages in COPD, several studies have used a range of markers to phenotype macrophages in COPD. Macrophages constitute a heterogeneous cell population, and, currently, proinflammatory M1 and anti-inflammatory M2 and M2-like cells are considered to represent the extremes of a pattern of macrophage polarization. In COPD, there is no clear evidence for a predominance of one of these phenotypes, and an intermediate phenotype may be present. Future studies are needed to establish the nature of this apparent COPD-specific macrophage subset, and to link macrophage dysfunction to COPD phenotypes.

摘要

巨噬细胞在慢性阻塞性肺疾病(COPD)中增加,并与 COPD 的严重程度相关,这一观察结果促使人们对 COPD 中巨噬细胞功能进行了大量研究。这些研究提供了证据表明,这些细胞通过释放各种介质,包括基质金属蛋白酶-12 等蛋白酶,导致组织损伤。此外,还发现 COPD 中的巨噬细胞清除呼吸道病原体和凋亡细胞的能力受损。体外研究表明,至少在一定程度上可以恢复 COPD 中巨噬细胞的吞噬功能。为了进一步了解 COPD 中巨噬细胞功能的这种改变,一些研究使用了一系列标志物来表型 COPD 中的巨噬细胞。巨噬细胞构成了一个异质细胞群体,目前,促炎 M1 和抗炎 M2 和 M2 样细胞被认为代表了巨噬细胞极化模式的极端。在 COPD 中,没有明确证据表明其中一种表型占主导地位,可能存在中间表型。未来的研究需要确定这种 COPD 特异性巨噬细胞亚群的性质,并将巨噬细胞功能障碍与 COPD 表型联系起来。

相似文献

1
Altered macrophage function in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中巨噬细胞功能的改变。
Ann Am Thorac Soc. 2013 Dec;10 Suppl:S180-5. doi: 10.1513/AnnalsATS.201305-123AW.
2
Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.鉴定慢性阻塞性肺疾病患者中糖皮质激素不敏感的肺巨噬细胞表型。
J Allergy Clin Immunol. 2014 Jan;133(1):207-16.e1-11. doi: 10.1016/j.jaci.2013.08.044. Epub 2013 Oct 28.
3
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.白藜芦醇可抑制慢性阻塞性肺疾病中肺泡巨噬细胞对外源内毒素暴露所释放的甾体类抵抗细胞因子。
Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):138-43. doi: 10.1111/j.1742-7843.2011.00707.x. Epub 2011 May 6.
4
Calcium restores the macrophage response to nontypeable haemophilus influenzae in chronic obstructive pulmonary disease.钙可恢复慢性阻塞性肺疾病患者巨噬细胞对流感嗜血杆菌非典型菌株的反应。
Am J Respir Cell Mol Biol. 2015 Jun;52(6):728-37. doi: 10.1165/rcmb.2014-0172OC.
5
Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的人肺泡巨噬细胞对不可分型流感嗜血杆菌的吞噬作用受损。
J Infect Dis. 2006 Nov 15;194(10):1375-84. doi: 10.1086/508428. Epub 2006 Oct 16.
6
Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease.阿奇霉素可改善慢性阻塞性肺疾病中巨噬细胞的吞噬功能及甘露糖受体的表达。
Am J Respir Crit Care Med. 2008 Jul 15;178(2):139-48. doi: 10.1164/rccm.200711-1666OC. Epub 2008 Apr 17.
7
Alveolar macrophages in chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)中的肺泡巨噬细胞。
Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL627-37.
8
Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects.低剂量阿奇霉素可改善慢性阻塞性肺疾病患者肺泡和单核细胞来源的巨噬细胞对细菌的吞噬作用。
Respirology. 2012 Jul;17(5):802-7. doi: 10.1111/j.1440-1843.2012.02135.x.
9
Pulmonary macrophages: key players in the innate defence of the airways.肺巨噬细胞:气道先天防御的关键细胞。
Thorax. 2015 Dec;70(12):1189-96. doi: 10.1136/thoraxjnl-2015-207020. Epub 2015 Aug 18.
10
Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.慢性阻塞性肺疾病患者、吸烟者和非吸烟者中不同的炎症细胞模式及巨噬细胞表型
Clin Exp Immunol. 2006 Sep;145(3):428-37. doi: 10.1111/j.1365-2249.2006.03154.x.

引用本文的文献

1
Investigating the comorbidity of COPD and tuberculosis, a computational study.一项关于慢性阻塞性肺疾病(COPD)与结核病共病情况的计算研究。
Front Syst Biol. 2023 Feb 23;3:940097. doi: 10.3389/fsysb.2023.940097. eCollection 2023.
2
The potential role of 1,25(OH)D (Active vitamin D) in modulating macrophage function; implications for chronic obstructive pulmonary disease (COPD).1,25(OH)D(活性维生素D)在调节巨噬细胞功能中的潜在作用;对慢性阻塞性肺疾病(COPD)的影响。
J Inflamm (Lond). 2025 Jul 1;22(1):26. doi: 10.1186/s12950-025-00452-y.
3
Sputum SLC40A1 as a Novel Biomarker is Increased in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
痰液中的溶质载体家族40成员1(SLC40A1)作为一种新型生物标志物,在慢性阻塞性肺疾病急性加重患者中升高。
Int J Chron Obstruct Pulmon Dis. 2025 Apr 2;20:943-955. doi: 10.2147/COPD.S499176. eCollection 2025.
4
Targeting BRD4 ameliorates experimental emphysema by disrupting super-enhancer in polarized alveolar macrophage.靶向BRD4通过破坏极化肺泡巨噬细胞中的超级增强子来改善实验性肺气肿。
Respir Res. 2025 Jan 31;26(1):46. doi: 10.1186/s12931-025-03120-0.
5
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?免疫疗法在诊断为慢性阻塞性肺疾病的非小细胞肺癌患者中的有效性:这是生存的潜在预后因素和免疫相关不良事件的危险因素吗?
Cancers (Basel). 2024 Mar 22;16(7):1251. doi: 10.3390/cancers16071251.
6
Heme oxygenase-1 determines the cell fate of ferroptotic death of alveolar macrophages in COPD.血红素加氧酶-1 决定 COPD 肺泡巨噬细胞铁死亡的细胞命运。
Front Immunol. 2023 May 5;14:1162087. doi: 10.3389/fimmu.2023.1162087. eCollection 2023.
7
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond.慢性阻塞性肺疾病中的囊性纤维化跨膜电导调节因子:呼吸上皮细胞内外的作用。
Eur Respir J. 2023 Apr 1;61(4). doi: 10.1183/13993003.01307-2022. Print 2023 Apr.
8
Severity of Lung Function Impairment Drives Transcriptional Phenotypes of COPD and Relates to Immune and Metabolic Processes.肺功能损伤严重程度驱动 COPD 的转录表型,并与免疫和代谢过程相关。
Int J Chron Obstruct Pulmon Dis. 2023 Mar 14;18:273-287. doi: 10.2147/COPD.S388297. eCollection 2023.
9
Macrophage Polarization: An Important Candidate Regulator for Lung Diseases.巨噬细胞极化:肺部疾病的重要候选调控因子
Molecules. 2023 Mar 4;28(5):2379. doi: 10.3390/molecules28052379.
10
NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease.NRF2 激活重编程氧化代谢缺陷,恢复慢性阻塞性肺疾病中巨噬细胞的功能。
Am J Respir Crit Care Med. 2023 Apr 15;207(8):998-1011. doi: 10.1164/rccm.202203-0482OC.